Exact Mass: 387.1584

Exact Mass Matches: 387.1584

Found 85 metabolites which its exact mass value is equals to given mass value 387.1584, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

flurazepam

flurazepam

C21H23ClFN3O (387.1514)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent CONFIDENCE standard compound; INTERNAL_ID 1631

   

Flurazepam

7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-2,3-dihydro-1H-1,4-benzodiazepin-2-one

C21H23ClFN3O (387.1514)


Flurazepam is only found in individuals that have used or taken this drug. It is a benzodiazepine derivative used mainly as a hypnotic. [PubChem]Flurazepam binds to an allosteric site on GABA-A receptors. Binding potentiates the action of GABA on GABA-A receptors by opening the chloride channel within the receptor, causing chloride influx and hyperpolarization. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

   

DV 7751a

6-{8-amino-6-azaspiro[3.4]octan-6-yl}-7-fluoro-2-methyl-10-oxo-4-oxa-1-azatricyclo[7.3.1.0^{5,13}]trideca-5(13),6,8,11-tetraene-11-carboxylic acid

C20H22FN3O4 (387.1594)


   

Benzyladenine 3-O-beta-D-glucoside

(2R,3R,4S,5S,6R)-2-[6-(benzylamino)-9H-purin-9-yl]-6-(hydroxymethyl)oxane-3,4,5-triol

C18H21N5O5 (387.1543)


Benzyladenine 3-o-beta-d-glucoside is a member of the class of compounds known as glycosylamines. Glycosylamines are compounds consisting of an amine with a beta-N-glycosidic bond to a carbohydrate, thus forming a cyclic hemiaminal ether bond (alpha-amino ether). Benzyladenine 3-o-beta-d-glucoside is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Benzyladenine 3-o-beta-d-glucoside can be found in soy bean, which makes benzyladenine 3-o-beta-d-glucoside a potential biomarker for the consumption of this food product.

   

Benzyladenine 7-O-beta-D-glucoside

(3R,4S,5S,6R)-2-[6-(benzylamino)-7H-purin-7-yl]-6-(hydroxymethyl)oxane-3,4,5-triol

C18H21N5O5 (387.1543)


Benzyladenine 7-o-beta-d-glucoside is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Benzyladenine 7-o-beta-d-glucoside can be found in soy bean, which makes benzyladenine 7-o-beta-d-glucoside a potential biomarker for the consumption of this food product.

   

Chrotacumine B

Chrotacumine B

C21H25NO6 (387.1682)


   

Androbiphenyline

Androbiphenyline

C21H25NO6 (387.1682)


   

16-Oxohasubanonine

16-Oxohasubanonine

C21H25NO6 (387.1682)


   

6-(2Methoxybenzylamino)purine-9-beta-D-ribofuranoside

6-(2Methoxybenzylamino)purine-9-beta-D-ribofuranoside

C18H21N5O5 (387.1543)


   

1-hydroxy-2,3,9,10-tetramethoxyaporphine N-oxide

1-hydroxy-2,3,9,10-tetramethoxyaporphine N-oxide

C21H25NO6 (387.1682)


   

Merenderine N-oxide

Merenderine N-oxide

C21H25NO6 (387.1682)


   

Marinacarboline A

Marinacarboline A

C23H21N3O3 (387.1583)


A natural product found in Marinactinospora thermotolerans.

   
   
   

SCHEMBL17866949

SCHEMBL17866949

C21H25NO6 (387.1682)


   

Cystodytin F

Cystodytin F

C23H21N3O3 (387.1583)


An alkaloid that is an enamide obtained by the formal condensation of 3-methylbut-2-enoic acid with 6-(2-amino-1-methoxyethyl)-4H-pyrido[2,3,4-kl]acridin-4-one. It is isolated from the Okinawan marine tunicate Cystodytes dellechiajei and exhibits cytotoxicity against human epidermoid carcinoma KB cells.

   

pestalamine A

pestalamine A

C21H25NO6 (387.1682)


   

Cystodytin G

Cystodytin G

C23H21N3O3 (387.1583)


An alkaloid that is an enamide obtained by the formal condensation of tiglic acid with 6-(2-amino-1-methoxyethyl)-4H-pyrido[2,3,4-kl]acridin-4-one. It is isolated from the Okinawan marine tunicate Cystodytes dellechiajei and exhibits cytotoxicity against human epidermoid carcinoma KB cells

   

(-)-narcotolinol|Narcotolinol

(-)-narcotolinol|Narcotolinol

C21H25NO6 (387.1682)


   
   
   

2-[6-(benzylamino)purin-7-yl]-6-(hydroxymethyl)oxane-3,4,5-triol

2-[6-(benzylamino)purin-7-yl]-6-(hydroxymethyl)oxane-3,4,5-triol

C18H21N5O5 (387.1543)


   

N6-benzyladenine-9-glucoside (BA9G)

N6-benzyladenine-9-glucoside (BA9G)

C18H21N5O5 (387.1543)


   
   
   
   
   
   
   

8-Hydroxymoxifloxacin

8-Hydroxymoxifloxacin

C20H22FN3O4 (387.1594)


   

tributyl-(3,5-dimethyl-1,2-oxazol-4-yl)stannane

tributyl-(3,5-dimethyl-1,2-oxazol-4-yl)stannane

C17H33NOSn (387.1584)


   

endo-8-Methyl-8-azabicyclo[3.2.1]octan-3-yl 2-hydroxy-2,2-diphenylacetate hydrochloride

endo-8-Methyl-8-azabicyclo[3.2.1]octan-3-yl 2-hydroxy-2,2-diphenylacetate hydrochloride

C22H26ClNO3 (387.1601)


   

N-[(1,1-Dimethylethoxy)carbonyl]-S-(diphenylmethyl)-L-cysteine

N-[(1,1-Dimethylethoxy)carbonyl]-S-(diphenylmethyl)-L-cysteine

C21H25NO4S (387.1504)


   

N-(tert-butoxycarbonyl)-3,4-dihydroxy-L-Pheny lalanine benzyl ester

N-(tert-butoxycarbonyl)-3,4-dihydroxy-L-Pheny lalanine benzyl ester

C21H25NO6 (387.1682)


   

1-[(TERT-BUTYL)OXYCARBONYL]-3-[4-(TRIFLUOROMETHYL)BENZYL]PIPERIDINE-3-CARBOXYLIC ACID

1-[(TERT-BUTYL)OXYCARBONYL]-3-[4-(TRIFLUOROMETHYL)BENZYL]PIPERIDINE-3-CARBOXYLIC ACID

C19H24F3NO4 (387.1657)


   

Allyl 2-Acetamido-3,4,6-tri-O-acetyl-2-deoxy--D-glucopyranoside

Allyl 2-Acetamido-3,4,6-tri-O-acetyl-2-deoxy--D-glucopyranoside

C17H25NO9 (387.1529)


   

6-Benzylaminopurine 9-(beta-D-glucoside)

(2R,5S)-2-[6-(benzylamino)purin-9-yl]-6-(hydroxymethyl)oxane-3,4,5-triol

C18H21N5O5 (387.1543)


   

7-[oxo-(4-phenyl-3,6-dihydro-2H-pyridin-1-yl)methyl]-3-prop-2-enyl-1H-quinazoline-2,4-dione

7-[oxo-(4-phenyl-3,6-dihydro-2H-pyridin-1-yl)methyl]-3-prop-2-enyl-1H-quinazoline-2,4-dione

C23H21N3O3 (387.1583)


   

8-Benzyloxy-5,7-diphenylquinoline

8-Benzyloxy-5,7-diphenylquinoline

C28H21NO (387.1623)


   

N-benzyl-9-(alpha-D-glucosyl)adenine

N-benzyl-9-(alpha-D-glucosyl)adenine

C18H21N5O5 (387.1543)


   

benzyladenine-7-N-glucoside

benzyladenine-7-N-glucoside

C18H21N5O5 (387.1543)


   

cis-Tuberonic acid glucoside

cis-Tuberonic acid glucoside

C18H27O9- (387.1655)


   

trans-Tuberonic acid glucoside

trans-Tuberonic acid glucoside

C18H27O9- (387.1655)


   

12-hydroxyjasmonate 12-O-beta-D-glucoside

12-hydroxyjasmonate 12-O-beta-D-glucoside

C18H27O9- (387.1655)


   

(Z)-5-[(1S,2R)-2-[2-[[(1S)-1-carboxy-2-phenylethyl]amino]-2-oxoethyl]-5-oxocyclopentyl]pent-3-enoic acid

(Z)-5-[(1S,2R)-2-[2-[[(1S)-1-carboxy-2-phenylethyl]amino]-2-oxoethyl]-5-oxocyclopentyl]pent-3-enoic acid

C21H25NO6 (387.1682)


   

Benzyladenine 7-O-beta-D-glucoside

Benzyladenine 7-O-beta-D-glucoside

C18H21N5O5 (387.1543)


   

N-(5-methyl-3-isoxazolyl)-2-(4-propan-2-yloxyphenyl)-4-quinolinecarboxamide

N-(5-methyl-3-isoxazolyl)-2-(4-propan-2-yloxyphenyl)-4-quinolinecarboxamide

C23H21N3O3 (387.1583)


   

2-(2-hydroxyphenyl)-3-[(E)-1-(4-methoxyphenyl)ethylideneamino]-1,2-dihydroquinazolin-4-one

2-(2-hydroxyphenyl)-3-[(E)-1-(4-methoxyphenyl)ethylideneamino]-1,2-dihydroquinazolin-4-one

C23H21N3O3 (387.1583)


   
   

2-benzoyl-N-(6-methoxy-3-pyridinyl)-3,4-dihydro-1H-isoquinoline-3-carboxamide

2-benzoyl-N-(6-methoxy-3-pyridinyl)-3,4-dihydro-1H-isoquinoline-3-carboxamide

C23H21N3O3 (387.1583)


   

4-methyl-N-[2-methyl-1,3-bis[(4-methyl-1,2,5-oxadiazol-3-yl)oxy]propan-2-yl]benzamide

4-methyl-N-[2-methyl-1,3-bis[(4-methyl-1,2,5-oxadiazol-3-yl)oxy]propan-2-yl]benzamide

C18H21N5O5 (387.1543)


   

2-(1-Adamantyl)-4-chloro-5-[(4-fluorophenyl)methylamino]-3-pyridazinone

2-(1-Adamantyl)-4-chloro-5-[(4-fluorophenyl)methylamino]-3-pyridazinone

C21H23ClFN3O (387.1514)


   

1-[2,5-Dimethyl-1-(phenylmethyl)-3-pyrrolyl]-2-[4-(1,3,4-oxadiazol-2-yl)phenoxy]ethanone

1-[2,5-Dimethyl-1-(phenylmethyl)-3-pyrrolyl]-2-[4-(1,3,4-oxadiazol-2-yl)phenoxy]ethanone

C23H21N3O3 (387.1583)


   

N-[2-[(2E)-2-[(3-hydroxyphenyl)methylidene]hydrazinyl]-2-oxoethyl]-2,2-diphenylacetamide

N-[2-[(2E)-2-[(3-hydroxyphenyl)methylidene]hydrazinyl]-2-oxoethyl]-2,2-diphenylacetamide

C23H21N3O3 (387.1583)


   

N-[(E)-(5-fluoro-2-hydroxyphenyl)methylideneamino]-N-(2-hydroxyphenyl)heptanediamide

N-[(E)-(5-fluoro-2-hydroxyphenyl)methylideneamino]-N-(2-hydroxyphenyl)heptanediamide

C20H22FN3O4 (387.1594)


   
   
   
   
   
   
   

N(2)-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]-N-butyl-3,3-dimethoxyalaninamide

N(2)-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]-N-butyl-3,3-dimethoxyalaninamide

C15H25N5O5S (387.1576)


   

N-acetyl-D-galactosamine-6-phosphocholine

N-acetyl-D-galactosamine-6-phosphocholine

C13H28N2O9P (387.1532)


A galactose phosphate consisting of N-acetyl-D-galactosamine having a choline phosphate group at the 6-position.

   

ST 19:5;O4;Gly

ST 19:5;O4;Gly

C21H25NO6 (387.1682)


   

MHY1485

MHY1485

C17H21N7O4 (387.1655)


MHY1485 is a potent cell-permeable mTOR activator that targets the ATP domain of mTOR. MHY1485 inhibits autophagy by suppression of fusion between autophagosomes and lysosomes[1]. MHY1485 is a potent cell-permeable mTOR activator that targets the ATP domain of mTOR. MHY1485 inhibits autophagy by suppression of fusion between autophagosomes and lysosomes[1].

   

(1r,10s)-3,4,11,12-tetramethoxy-17-methyl-17-azatetracyclo[8.4.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,11-tetraene-13,16-dione

(1r,10s)-3,4,11,12-tetramethoxy-17-methyl-17-azatetracyclo[8.4.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,11-tetraene-13,16-dione

C21H25NO6 (387.1682)


   

5,17-dihydroxy-3,4,16-trimethoxy-11-methyl-11-azatetracyclo[8.7.1.0²,⁷.0¹⁴,¹⁸]octadeca-1(17),2(7),3,5,14(18),15-hexaen-11-ium-11-olate

5,17-dihydroxy-3,4,16-trimethoxy-11-methyl-11-azatetracyclo[8.7.1.0²,⁷.0¹⁴,¹⁸]octadeca-1(17),2(7),3,5,14(18),15-hexaen-11-ium-11-olate

C21H25NO6 (387.1682)


   

(5s)-5-{[2-(hydroxymethyl)-3,4-dimethoxyphenyl]methyl}-6-methyl-2h,5h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-4-ol

(5s)-5-{[2-(hydroxymethyl)-3,4-dimethoxyphenyl]methyl}-6-methyl-2h,5h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-4-ol

C21H25NO6 (387.1682)


   

5-{[2-(hydroxymethyl)-3,4-dimethoxyphenyl]methyl}-6-methyl-2h,5h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-4-ol

5-{[2-(hydroxymethyl)-3,4-dimethoxyphenyl]methyl}-6-methyl-2h,5h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-4-ol

C21H25NO6 (387.1682)


   

16-oxohasubanonine

NA

C21H25NO6 (387.1682)


{"Ingredient_id": "HBIN001944","Ingredient_name": "16-oxohasubanonine","Alias": "NA","Ingredient_formula": "C21H25NO6","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "16330","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

n-(2-methoxy-2-{12-oxo-8,14-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,10,13,15-octaen-10-yl}ethyl)-3-methylbut-2-enimidic acid

n-(2-methoxy-2-{12-oxo-8,14-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,10,13,15-octaen-10-yl}ethyl)-3-methylbut-2-enimidic acid

C23H21N3O3 (387.1583)


   

[(1r,3r)-10-hydroxy-7-(methylamino)-1-(3-methylbutyl)-6,9-dioxo-1h,3h,4h-naphtho[2,3-c]pyran-3-yl]acetic acid

[(1r,3r)-10-hydroxy-7-(methylamino)-1-(3-methylbutyl)-6,9-dioxo-1h,3h,4h-naphtho[2,3-c]pyran-3-yl]acetic acid

C21H25NO6 (387.1682)


   

3-(2-{7,7-dimethyl-3h-chromeno[6,5-b]pyrrol-1-yl}ethyl)-2-hydroxyquinazolin-4-one

3-(2-{7,7-dimethyl-3h-chromeno[6,5-b]pyrrol-1-yl}ethyl)-2-hydroxyquinazolin-4-one

C23H21N3O3 (387.1583)


   

(2e)-n-(2-methoxy-2-{12-oxo-8,14-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,10,13,15-octaen-10-yl}ethyl)-2-methylbut-2-enimidic acid

(2e)-n-(2-methoxy-2-{12-oxo-8,14-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,10,13,15-octaen-10-yl}ethyl)-2-methylbut-2-enimidic acid

C23H21N3O3 (387.1583)


   

3,4,11,12-tetramethoxy-17-methyl-17-azatetracyclo[8.4.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,11-tetraene-13,16-dione

3,4,11,12-tetramethoxy-17-methyl-17-azatetracyclo[8.4.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,11-tetraene-13,16-dione

C21H25NO6 (387.1682)


   

n-[(2s)-1-(4-methoxyphenyl)-3-oxo-4-(3,4,5-trimethoxyphenyl)butan-2-yl]carboximidic acid

n-[(2s)-1-(4-methoxyphenyl)-3-oxo-4-(3,4,5-trimethoxyphenyl)butan-2-yl]carboximidic acid

C21H25NO6 (387.1682)


   

[10-hydroxy-7-(methylamino)-1-(3-methylbutyl)-6,9-dioxo-1h,3h,4h-naphtho[2,3-c]pyran-3-yl]acetic acid

[10-hydroxy-7-(methylamino)-1-(3-methylbutyl)-6,9-dioxo-1h,3h,4h-naphtho[2,3-c]pyran-3-yl]acetic acid

C21H25NO6 (387.1682)


   

(3s,4r)-4-(5,7-dihydroxy-2-methyl-4-oxochromen-8-yl)-1-methylpiperidin-3-yl 2-methylbut-2-enoate

(3s,4r)-4-(5,7-dihydroxy-2-methyl-4-oxochromen-8-yl)-1-methylpiperidin-3-yl 2-methylbut-2-enoate

C21H25NO6 (387.1682)


   

n-[(8s)-6-hydroxy-5,13,14,15-tetramethoxytricyclo[9.4.0.0²,⁷]pentadeca-1(15),2,4,6,11,13-hexaen-8-yl]ethanimidic acid

n-[(8s)-6-hydroxy-5,13,14,15-tetramethoxytricyclo[9.4.0.0²,⁷]pentadeca-1(15),2,4,6,11,13-hexaen-8-yl]ethanimidic acid

C21H25NO6 (387.1682)


   

(9r,10s)-16-hydroxy-4,5,14,15-tetramethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-10-ium-10-olate

(9r,10s)-16-hydroxy-4,5,14,15-tetramethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-10-ium-10-olate

C21H25NO6 (387.1682)


   

(2r,3r,4z)-5-[3-amino-2-(butoxycarbonyl)phenyl]-3-hydroxypent-4-en-2-yl furan-2-carboxylate

(2r,3r,4z)-5-[3-amino-2-(butoxycarbonyl)phenyl]-3-hydroxypent-4-en-2-yl furan-2-carboxylate

C21H25NO6 (387.1682)


   

5-[3-amino-2-(butoxycarbonyl)phenyl]-3-hydroxypent-4-en-2-yl furan-2-carboxylate

5-[3-amino-2-(butoxycarbonyl)phenyl]-3-hydroxypent-4-en-2-yl furan-2-carboxylate

C21H25NO6 (387.1682)


   

n-[1-(4-methoxyphenyl)-3-oxo-4-(3,4,5-trimethoxyphenyl)butan-2-yl]carboximidic acid

n-[1-(4-methoxyphenyl)-3-oxo-4-(3,4,5-trimethoxyphenyl)butan-2-yl]carboximidic acid

C21H25NO6 (387.1682)


   

n-{6-hydroxy-5,13,14,15-tetramethoxytricyclo[9.4.0.0²,⁷]pentadeca-1(15),2,4,6,11,13-hexaen-8-yl}ethanimidic acid

n-{6-hydroxy-5,13,14,15-tetramethoxytricyclo[9.4.0.0²,⁷]pentadeca-1(15),2,4,6,11,13-hexaen-8-yl}ethanimidic acid

C21H25NO6 (387.1682)


   

(9r)-16-hydroxy-4,5,14,15-tetramethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-10-ium-10-olate

(9r)-16-hydroxy-4,5,14,15-tetramethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-10-ium-10-olate

C21H25NO6 (387.1682)